GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » PB Ratio

Gennex Laboratories (BOM:531739) PB Ratio : 2.23 (As of Dec. 16, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Gennex Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-16), Gennex Laboratories's share price is ₹17.67. Gennex Laboratories's Book Value per Share for the quarter that ended in Sep. 2024 was ₹7.93. Hence, Gennex Laboratories's PB Ratio of today is 2.23.

The historical rank and industry rank for Gennex Laboratories's PB Ratio or its related term are showing as below:

BOM:531739' s PB Ratio Range Over the Past 10 Years
Min: 0.7   Med: 2.02   Max: 4.23
Current: 2.23

During the past 13 years, Gennex Laboratories's highest PB Ratio was 4.23. The lowest was 0.70. And the median was 2.02.

BOM:531739's PB Ratio is ranked worse than
54.36% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs BOM:531739: 2.23

During the past 12 months, Gennex Laboratories's average Book Value Per Share Growth Rate was 62.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 35.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 22.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.70% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Gennex Laboratories was 35.70% per year. The lowest was -53.20% per year. And the median was 6.20% per year.

Back to Basics: PB Ratio


Gennex Laboratories PB Ratio Historical Data

The historical data trend for Gennex Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennex Laboratories PB Ratio Chart

Gennex Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 1.25 2.17 1.23 2.11

Gennex Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 - 2.11 - 2.89

Competitive Comparison of Gennex Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Gennex Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennex Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gennex Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Gennex Laboratories's PB Ratio falls into.



Gennex Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Gennex Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=17.67/7.932
=2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Gennex Laboratories  (BOM:531739) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Gennex Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Gennex Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gennex Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.

Gennex Laboratories Headlines

No Headlines